Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use

Jayne Tierney and colleagues offer guidance on how to spot a well-designed and well-conducted individual participant data meta-analysis.

[1]  Emily Newman,et al.  PROSPERO International prospective register of systematic reviews , 2017 .

[2]  S. Burdett,et al.  How individual participant data meta-analyses have influenced trial design, conduct, and analysis , 2015, Journal of clinical epidemiology.

[3]  Richard D Riley,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement , 2015 .

[4]  François Gueyffier,et al.  Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study , 2015, BMJ : British Medical Journal.

[5]  F Gueyffier,et al.  Multivariate meta-analysis using individual participant data , 2014 .

[6]  Karel G M Moons,et al.  A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta‐analysis , 2013, Statistics in medicine.

[7]  Ewout W. Steyerberg,et al.  Individual participant data meta-analyses should not ignore clustering , 2013, Journal of clinical epidemiology.

[8]  Jayne F Tierney,et al.  Can trial quality be reliably assessed from published reports of cancer trials: evaluation of risk of bias assessments in systematic reviews , 2013, BMJ : British Medical Journal.

[9]  Douglas G. Altman,et al.  Statistical Analysis of Individual Participant Data Meta-Analyses: A Comparison of Methods and Recommendations for Practice , 2012, PloS one.

[10]  B. Djulbegovic,et al.  Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols. , 2012, Journal of clinical epidemiology.

[11]  Richard D Riley,et al.  Individual participant data meta-analysis of prognostic factor studies: state of the art? , 2012, BMC Medical Research Methodology.

[12]  A. Sutton,et al.  Assessment of publication bias, selection bias, and unavailable data in meta-analyses using individual participant data: a database survey , 2012, BMJ : British Medical Journal.

[13]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[14]  L. Stewart,et al.  Publication of IPD meta-analyses in the Cochrane Database of Systematic Reviews: potential barriers and opportunities , 2011 .

[15]  J F Tierney,et al.  A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners. , 2011, Journal of clinical epidemiology.

[16]  Jack Bowden,et al.  Individual patient data meta‐analysis of time‐to‐event outcomes: one‐stage versus two‐stage approaches for estimating the hazard ratio under a random effects model , 2011, Research synthesis methods.

[17]  J. Ioannidis,et al.  Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.

[18]  David Moher,et al.  An international registry of systematic-review protocols , 2011, The Lancet.

[19]  C. Bias.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials , 2011 .

[20]  Theo Stijnen,et al.  Random effects meta‐analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data , 2010, Statistics in medicine.

[21]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[22]  Douglas G Altman,et al.  The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews , 2010, BMJ : British Medical Journal.

[23]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[24]  Thomas Mathew,et al.  Comparison of One‐Step and Two‐Step Meta‐Analysis Models Using Individual Patient Data , 2010, Biometrical journal. Biometrische Zeitschrift.

[25]  A. Hoes,et al.  Confounding of subgroup analyses in randomized data. , 2009, Archives of internal medicine.

[26]  Richard D Riley,et al.  Meta‐analysis of diagnostic test studies using individual patient data and aggregate data , 2008, Statistics in medicine.

[27]  D. Alberts,et al.  Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  David Moher,et al.  Addressing Reporting Biases , 2008 .

[29]  Lesley A. Stewart,et al.  Reviews of Individual Patient Data , 2008 .

[30]  D. Altman,et al.  Assessing Risk of Bias in Included Studies , 2008 .

[31]  A. Hoes,et al.  Empirical comparison of subgroup effects in conventional and individual patient data meta-analyses , 2008, International Journal of Technology Assessment in Health Care.

[32]  Richard D Riley,et al.  Meta‐analysis of continuous outcomes combining individual patient data and aggregate data , 2008, Statistics in medicine.

[33]  G. Biondi-Zoccai,et al.  Early glycoprotein IIb–IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis , 2008, Heart.

[34]  A Engert,et al.  High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults. , 2008, The Cochrane database of systematic reviews.

[35]  P. Williamson,et al.  A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes , 2007, Clinical trials.

[36]  Richard D Riley,et al.  Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. , 2007, Journal of clinical epidemiology.

[37]  Thomas A Trikalinos,et al.  The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey , 2007, Canadian Medical Association Journal.

[38]  S. Yoshida,et al.  An individual patient data meta-analysis of adjuvant therapy with uracil–tegafur (UFT) in patients with curatively resected rectal cancer , 2007, British Journal of Cancer.

[39]  Wolfgang Viechtbauer,et al.  Publication bias in meta-analysis: Prevention, assessment and adjustments , 2007, Psychometrika.

[40]  M. Borenstein,et al.  Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments , 2006 .

[41]  Kay Dickersin,et al.  Publication Bias: Recognizing the Problem, Understanding Its Origins and Scope, and Preventing Harm , 2006 .

[42]  Lesley A. Stewart,et al.  Do Systematic Reviews Based on Individual Patient Data Offer a Means of Circumventing Biases Associated with Trial Publications , 2006 .

[43]  青儀 健二郎,et al.  What's going on 乳癌 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group(EBCTCG). Lancet. 2005; 365: 1687-717. PMID: 15894097.--早期乳癌に対する化学療法・内分泌療法が乳癌再発・15年生存率に及 , 2006 .

[44]  Mark C Simmonds,et al.  Meta-analysis of individual patient data from randomized trials: a review of methods used in practice , 2005, Clinical trials.

[45]  Paula R Williamson,et al.  Investigating heterogeneity in an individual patient data meta‐analysis of time to event outcomes , 2005, Statistics in medicine.

[46]  Lesley A Stewart,et al.  Investigating patient exclusion bias in meta-analysis. , 2004, International journal of epidemiology.

[47]  A. Grant,et al.  Value of updating a systematic review in surgery using individual patient data , 2004, The British journal of surgery.

[48]  Lesley A Stewart,et al.  PUBLICATION BIAS AND META-ANALYSES , 2003, International Journal of Technology Assessment in Health Care.

[49]  Kenneth F Schulz,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Exclusions before Randomisation Exclusions after Randomisation Sample Size Slippages in Randomised Trials: Exclusions and the Lost and Wayward , 2022 .

[50]  L. Stewart,et al.  To IPD or not to IPD? , 2002, Evaluation & the health professions.

[51]  Harold I Feldman,et al.  Individual patient‐ versus group‐level data meta‐regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head , 2002, Statistics in medicine.

[52]  J. Pignon,et al.  Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer. , 2001, Controlled clinical trials.

[53]  A Whitehead,et al.  Meta‐analysis of ordinal outcomes using individual patient data , 2001, Statistics in medicine.

[54]  A Whitehead,et al.  Meta‐analysis of continuous outcome data from individual patients , 2001, Statistics in medicine.

[55]  H Goldstein,et al.  A multilevel model framework for meta-analysis of clinical trials with binary outcomes. , 2000, Statistics in medicine.

[56]  J M Lachin,et al.  Statistical considerations in the intent-to-treat principle. , 2000, Controlled clinical trials.

[57]  Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. , 2000, The Cochrane database of systematic reviews.

[58]  T. Mathew,et al.  On the Equivalence of Meta‐Analysis Using Literature and Using Individual Patient Data , 1999, Biometrics.

[59]  S. Burdett,et al.  Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.

[60]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[61]  I Olkin,et al.  Comparison of meta-analysis versus analysis of variance of individual patient data. , 1998, Biometrics.

[62]  R. Sylvester,et al.  Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997 .

[63]  D. Crowther.  Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997, The Lancet.

[64]  L. Stewart,et al.  Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. , 1995, Statistics in medicine.

[65]  L F Burmeister,et al.  A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage. , 1995, JAMA.

[66]  I. Chalmers.  The Cochrane Collaboration: Preparing, Maintaining, and Disseminating Systematic Reviews of the Effects of Health Care , 1993, Annals of the New York Academy of Sciences.

[67]  M. Parmar,et al.  Meta-analysis of the literature or of individual patient data: is there a difference? , 1993, The Lancet.

[68]  D. Alberts,et al.  Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group. , 1991, BMJ.

[69]  Douglas G. Altman,et al.  RANDOMISATION : ESSENTIAL FOR REDUCING BIAS , 1991 .

[70]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[71]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[72]  Akademie der Wissenschaften der Ddr.  Biometrical journal : Biometrische Zeitschrift. , 1977 .

[73]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.